Newark, NJ, United States of America

Zi Wei Chen

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Biodelivery Sciences International, Inc., Rutgers, The State University of New Jersey. Active years: 2013-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zi Wei Chen. Retrieved from https://idiyas.com/inventor/zi-wei-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Zi Wei Chen

Introduction

Zi Wei Chen is an accomplished inventor based in Newark, NJ. He has made significant contributions to the field of biotechnology, particularly in the development of novel compositions aimed at protein expression.

Latest Patents

Zi Wei Chen holds two patents, both of which focus on cochleate compositions directed against the expression of proteins. These patents disclose novel siRNA-cochleate and morpholino-cochleate compositions. Additionally, they outline methods for making and using these innovative compositions.

Career Highlights

Throughout his career, Zi Wei Chen has worked with notable organizations, including Biodelivery Sciences International, Inc. and Rutgers, the State University of New Jersey. His work has been instrumental in advancing the understanding and application of cochleate technology in therapeutic settings.

Collaborations

Zi Wei Chen has collaborated with esteemed colleagues such as Susan Gould-Fogerite and Raphael J Mannino. These partnerships have contributed to the success of his research and innovations.

Conclusion

Zi Wei Chen's work in the field of biotechnology exemplifies the impact of innovative thinking on protein expression technologies. His patents and collaborations highlight his commitment to advancing scientific knowledge and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…